HER2 Support Group Forums - View Single Post - ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

News · 08-30-2011, 04:31 AM

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

More...

08-30-2011, 04:31 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,112	ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma. More...